Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Birchmeier, Walter Prof. Dr. (1) Dahlmann, Mathias Dr. (3) Daniel, Peter Prof. Dr. (4) Daumke, Oliver Prof. Dr. (1) Hinz, Michael Dr. (1) Ivics, Zoltan Dr. (1) Izsvak, Zsuzsanna Dr. (1) Kobelt, Dennis Dr. (9) Mathas, Stephan Dr. (10) Nguyen, Tam Hoai Dr. (1) Pezzutto, Antonio Prof. Dr. (2) Rajewsky, Klaus Prof. Dr. (1) Rocks, Oliver Dr. (1) Scheidereit, Claus Prof. Dr. (2) Schlag, Peter M. Prof. Dr. (86) Schmitt, Clemens Prof. Dr. (1) Specker, Edgar Dr. (2) Stein, Ulrike Prof. Dr. (30) von Kries, Jens Peter Dr. (2) Walther, Wolfgang Prof. Dr. (25) Wollert-Wulf, Brigitte (4) (-) Janz, Martin Dr. (14) (-) Lusatis, Simone (1) (-) Smith, Janice (5) Bioinformatics and Omics Data Science (1) Bioinformatik der Genregulation (2) (-) Biologie maligner Lymphome (14) Entwicklungsbiologie / Signaltransduktion in Nerven und Muskelzellen (2) Epigenetische Regulation und Chromatinstruktur (1) Genetik und Genomik von Herz- Kreislauferkrankungen (1) Immunregulation und Krebs (1) Mathematische Modellierung zellulärer Prozesse (1) Nicht-Kodierende RNAs und Mechanismen der Genregulation im Cytoplasma (2) Proteom Dynamik (17) RNA Biologie und Posttranscriptionale Regulation (2) Strukturbiologie Membran-assoziierter Prozesse (1) Systembiologie von Gen-regulatorischen Elementen (1) Systems Biology Imaging (1) (-) Translationale Onkologie solider Tumore (6) 1999 (1) 2000 (1) 2002 (1) (-) 2003 (3) 2004 (2) 2005 (2) (-) 2006 (5) 2007 (2) 2008 (3) 2009 (5) 2010 (1) 2011 (5) (-) 2012 (3) (-) 2013 (3) 2014 (2) 2015 (2) 2016 (2) (-) 2017 (5) 2018 (1) 2019 (1) 2020 (5) 2021 (4) 2022 (5) 2023 (8) 2024 (1) 19 Ergebnisse: Active Filter: Janz, Martin Dr.Lusatis, SimoneSmith, JaniceBiologie maligner LymphomeTranslationale Onkologie solider Tumore20032006201220132017 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 01. Januar 2003 / J Biol Chem YB-1 as a cell cycle-regulated transcription factor facilitating cyclin A and cyclin B1 gene expression K. Juerchott S. Bergmann U. Stein W. Walther M. Janz I. Manni G. Piaggio E. Fietze M. Dietel H.D. Royer 01. August 2003 / Blood Inhibition of NF-κB essentially contributes to arsenic-induced apoptosis S. Mathas A. Lietz M. Janz M. Hinz F. Jundt C. Scheidereit K. Bommert B. Doerken 15. Mai 2006 / Cell Cycle Reprogramming of B lymphoid cells in human lymphoma pathogenesis M. Janz B. Doerken S. Mathas 01. November 2006 / Gastroenterology The metastasis-associated gene S100A4 is a novel target of beta-catenin/T-cell factor (TCF) signaling in colon cancer U. Stein F. Arlt W. Walther J. Smith T. Waldman E.D. Harris S.D. Mertins C.W. Heizmann D. Allard W. Birchmeier P.M. Schlag R.H. Shoemaker 01. Mai 2003 / Blood Macrophage inflammatory protein 1-alpha (MIP-1alpha) triggers migration and signaling cascades mediating survival and proliferation in multiple myeloma (MM) cells S. Lentzsch M. Gries M. Janz R. Bargou B. Doerken M.Y. Mapara 01. April 2006 / Cell Death Differ Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma I. Sturm C. Stephan B. Gillissen R. Siebert M. Janz S. Radetzki K. Jung S. Loening B. Doerken P.T. Daniel 01. Februar 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken 15. März 2006 / Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou 01. August 2017 / Ann Oncol Prognostic value of MACC1 and proficient mismatch repair status for recurrence risk prediction in stage II colon cancer patients: the BIOGRID studies U.P. Rohr P. Herrmann K. Ilm H. Zhang S. Lohmann A. Reiser A. Muranyi J. Smith S. Burock M. Osterland K. Leith S. Singh P. Brunhoeber R. Bowermaster J. Tie M. Christie H.L. Wong P. Waring K. Shanmugam P. Gibbs U. Stein 01. Juni 2017 / PLoS Biol Statin and rottlerin small-molecule inhibitors restrict colon cancer progression and metastasis via MACC1 M. Juneja D. Kobelt W. Walther C. Voss J. Smith E. Specker M. Neuenschwander B.O. Gohlke M. Dahlmann S. Radetzki R. Preissner J.P. von Kries P.M. Schlag U. Stein Seitennummerierung Aktuelle Seite 1 Seite 2 Nächste Seite Next › Letzte Seite Last »
01. Januar 2003 / J Biol Chem YB-1 as a cell cycle-regulated transcription factor facilitating cyclin A and cyclin B1 gene expression K. Juerchott S. Bergmann U. Stein W. Walther M. Janz I. Manni G. Piaggio E. Fietze M. Dietel H.D. Royer
01. August 2003 / Blood Inhibition of NF-κB essentially contributes to arsenic-induced apoptosis S. Mathas A. Lietz M. Janz M. Hinz F. Jundt C. Scheidereit K. Bommert B. Doerken
15. Mai 2006 / Cell Cycle Reprogramming of B lymphoid cells in human lymphoma pathogenesis M. Janz B. Doerken S. Mathas
01. November 2006 / Gastroenterology The metastasis-associated gene S100A4 is a novel target of beta-catenin/T-cell factor (TCF) signaling in colon cancer U. Stein F. Arlt W. Walther J. Smith T. Waldman E.D. Harris S.D. Mertins C.W. Heizmann D. Allard W. Birchmeier P.M. Schlag R.H. Shoemaker
01. Mai 2003 / Blood Macrophage inflammatory protein 1-alpha (MIP-1alpha) triggers migration and signaling cascades mediating survival and proliferation in multiple myeloma (MM) cells S. Lentzsch M. Gries M. Janz R. Bargou B. Doerken M.Y. Mapara
01. April 2006 / Cell Death Differ Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma I. Sturm C. Stephan B. Gillissen R. Siebert M. Janz S. Radetzki K. Jung S. Loening B. Doerken P.T. Daniel
01. Februar 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken
15. März 2006 / Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou
01. August 2017 / Ann Oncol Prognostic value of MACC1 and proficient mismatch repair status for recurrence risk prediction in stage II colon cancer patients: the BIOGRID studies U.P. Rohr P. Herrmann K. Ilm H. Zhang S. Lohmann A. Reiser A. Muranyi J. Smith S. Burock M. Osterland K. Leith S. Singh P. Brunhoeber R. Bowermaster J. Tie M. Christie H.L. Wong P. Waring K. Shanmugam P. Gibbs U. Stein
01. Juni 2017 / PLoS Biol Statin and rottlerin small-molecule inhibitors restrict colon cancer progression and metastasis via MACC1 M. Juneja D. Kobelt W. Walther C. Voss J. Smith E. Specker M. Neuenschwander B.O. Gohlke M. Dahlmann S. Radetzki R. Preissner J.P. von Kries P.M. Schlag U. Stein